title: Quinolone prophylaxis in neutropenic patients - efficacy versus resistance.
abstract: To assess the efficacy of quinolones in the prophylaxis of infections in neutropenic patients with acute non-lymphocytic leukemia, and to evaluate the emergence of quinolone resistance in two University Hospitals in Brazil, we retrospectively compared 101 consecutive episodes of neutropenia managed with quinolone prophylaxis between 1989 and November 1993, and 26 previous episodes without prophylaxis, and reviewed the results of in vitro sensitivity of Gram-negative strains to quinolones in the same period. Prophylaxis with quinolones resulted in less episodes of bacteremias (21% vs. 69%, p=10(-7)), including Gram-negative bacteremias (6% vs. 38%, p=10(-5)), with no statistically significant difference in the death rate (18% vs. 31%, p=0.14, 95% confidence interval -6-32). The resistance of Gramnegative strains to quinolones rose from 7% to 18% between 1990 and 1993 (p=10(-5)). The resistance against ceftazidime and amikacin, the agents used in the empirical antibiotic therapy, increased in the same proportion as the quinolones. Given the limited benefit of quinolones as prophylaxis and the increasing number of quinolone-resistant Gram-negative strains observed in our hospitals, the use of quinolones as prophylaxis must be seriously questioned. A stricter control of the use of quinolones in these hospitals might decrease resistance.
authors: STATE UNIV RIO DE JANEIRO HOSP,BR-20551030 RIO JANEIRO,BRAZIL.
authors: M
authors: M
authors: Nucci
authors: W
authors: W
authors: Pulcheri
authors: N
authors: N
authors: Spector
authors: A
authors: A
authors: Bueno
authors: S
authors: S
authors: Silveira
authors: D
authors: D
authors: Marangoni
authors: R
authors: R
authors: Ferreira
authors: H
authors: H
authors: Deoliveira